Table 3 Immunohistochemical and EBER in situ hybridization results
Patient 1 | Patient 2 | Patient 3 | Patient 4 | Patient 5 | Patient 6 | Patient 7 | Patient 8 | Patient 9 | Total | |
|---|---|---|---|---|---|---|---|---|---|---|
CD3 | + | + | + | + | + | ++ | + | ++ | + | 9 (100%) |
CD4 | – | – | – | – | – | – | – | – | – | – |
CD5 | – | – | + | – | – | + | – | – | – | 3 (33.3%) |
CD8 | – | + | + | + | – | – | – | – | – | 3 (33.3%) |
CD20 | – | – | – | – | – | – | – | – | – | – |
CD56 (N-CAM) | + | – | + | + | – | + | – | ++ | + | 6 (66.7%) |
CD57 (NK1) | – | + | – | + | – | + | – | – | – | 3 (33.3%) |
Granzyme B | + | + | + | + | + | – | + | + | + | 7 (77.8%) |
LMP-1 | – | + | + | – | + | + | – | – | – | 4 (44.4%) |
EBER ISH | + | + | + | + | + | + | + | + | + | 9 (100%) |